Search results:

Gene ID	Symbol	Synonyms	Official Full Name	Location
The pahtway p764 has 137 genes in the original annotation. Currently, there are 105 genes in SZGR (with evidence in schizophrenia) that are present at this pathway.
983	CDK1	CDC2 \| CDC28A \| P34CDC2	cyclin-dependent kinase 1	10q21.1
5728	PTEN	10q23del \| BZS \| CWS1 \| DEC \| GLM2 \| MHAM \| MMAC1 \| PTEN1 \| TEP1	phosphatase and tensin homolog	10q23.3
1147	CHUK	IKBKA \| IKK-alpha \| IKK1 \| IKKA \| NFKBIKA \| TCF16	conserved helix-loop-helix ubiquitous kinase	10q24-q25
161	AP2A2	ADTAB \| CLAPA2 \| HIP-9 \| HIP9 \| HYPJ	adaptor related protein complex 2 alpha 2 subunit	11p15.5
3265	HRAS	C-BAS/HAS \| C-H-RAS \| C-HA-RAS1 \| CTLO \| H-RASIDX \| HAMSV \| HRAS1 \| RASH1 \| p21ras	Harvey rat sarcoma viral oncogene homolog	11p15.5
6199	RPS6KB2	KLS \| P70-beta \| P70-beta-1 \| P70-beta-2 \| S6K-beta2 \| S6K2 \| SRK \| STK14B \| p70(S6K)-beta \| p70S6Kb	ribosomal protein S6 kinase B2	11q13.2
3709	ITPR2	ANHD \| CFAP48 \| INSP3R2 \| IP3R2	inositol 1,4,5-trisphosphate receptor type 2	12p11
3845	KRAS	C-K-RAS \| CFC2 \| K-RAS2A \| K-RAS2B \| K-RAS4A \| K-RAS4B \| KI-RAS \| KRAS1 \| KRAS2 \| NS \| NS3 \| RALD \| RASK2	Kirsten rat sarcoma viral oncogene homolog	12p12.1
1027	CDKN1B	CDKN4 \| KIP1 \| MEN1B \| MEN4 \| P27KIP1	cyclin-dependent kinase inhibitor 1B	12p13.1-p12
3164	NR4A1	GFRP1 \| HMR \| N10 \| NAK-1 \| NGFIB \| NP10 \| NUR77 \| TR3	nuclear receptor subfamily 4 group A member 1	12q13
466	ATF1	EWS-ATF1 \| FUS/ATF-1 \| TREB36	activating transcription factor 1	12q13
112	ADCY6	AC6 \| LCCS8	adenylate cyclase 6	12q13.12
4193	MDM2	ACTFS \| HDMX \| hdm2	MDM2 proto-oncogene	12q14.3-q15
1848	DUSP6	HH19 \| MKP3 \| PYST1	dual specificity phosphatase 6	12q21.33
2308	FOXO1	FKH1 \| FKHR \| FOXO1A	forkhead box O1	13q14.1
8660	IRS2	IRS-2	insulin receptor substrate 2	13q34
801	CALM1	CALML2 \| CAMI \| CPVT4 \| DD132 \| LQT14 \| PHKD \| caM	calmodulin 1 (phosphorylase kinase, delta)	14q32.11
207	AKT1	AKT \| CWS6 \| PKB \| PKB-ALPHA \| PRKBA \| RAC \| RAC-ALPHA	v-akt murine thymoma viral oncogene homolog 1	14q32.32
5604	MAP2K1	CFC3 \| MAPKK1 \| MEK1 \| MKK1 \| PRKMK1	mitogen-activated protein kinase kinase 1	15q22.1-q22.33
5607	MAP2K5	HsT17454 \| MAPKK5 \| MEK5 \| PRKMK5	mitogen-activated protein kinase kinase 5	15q23
4205	MEF2A	ADCAD1 \| RSRFC4 \| RSRFC9 \| mef2	myocyte enhancer factor 2A	15q26
5595	MAPK3	ERK-1 \| ERK1 \| ERT2 \| HS44KDAP \| HUMKER1A \| P44ERK1 \| P44MAPK \| PRKM3 \| p44-ERK1 \| p44-MAPK	mitogen-activated protein kinase 3	16p11.2
64223	MLST8	GBL \| GbetaL \| LST8 \| POP3 \| WAT1	MTOR associated protein, LST8 homolog	16p13.3
7249	TSC2	LAM \| PPP1R160 \| TSC4	tuberous sclerosis 2	16p13.3
115	ADCY9	AC9 \| ACIX	adenylate cyclase 9	16p13.3
113	ADCY7	AC7	adenylate cyclase 7	16q12.1
5598	MAPK7	BMK1 \| ERK4 \| ERK5 \| PRKM7	mitogen-activated protein kinase 7	17p11.2
1398	CRK	CRKII \| p38	v-crk avian sarcoma virus CT10 oncogene homolog	17p13.3
1845	DUSP3	VHR	dual specificity phosphatase 3	17q21
6774	STAT3	ADMIO \| APRF \| HIES	signal transducer and activator of transcription 3 (acute-phase response factor)	17q21.31
2885	GRB2	ASH \| EGFRBP-GRB2 \| Grb3-3 \| MST084 \| MSTP084 \| NCKAP2	growth factor receptor bound protein 2	17q24-q25
5573	PRKAR1A	ACRDYS1 \| ADOHR \| CAR \| CNC \| CNC1 \| PKR1 \| PPNAD1 \| PRKAR1 \| TSE1	protein kinase cAMP-dependent type I regulatory subunit alpha	17q24.2
5578	PRKCA	AAG6 \| PKC-alpha \| PKCA \| PRKACA	protein kinase C alpha	17q24.2
116	ADCYAP1	PACAP	adenylate cyclase activating polypeptide 1 (pituitary)	18p11
6014	RIT2	RIBA \| RIN \| ROC2	Ras-like without CAAX 2	18q12.3
5605	MAP2K2	CFC4 \| MAPKK2 \| MEK2 \| MKK2 \| PRKMK2	mitogen-activated protein kinase kinase 2	19p13.3
208	AKT2	HIHGHH \| PKBB \| PKBBETA \| PRKBB \| RAC-BETA	v-akt murine thymoma viral oncogene homolog 2	19q13.1-q13.2
2931	GSK3A	-	glycogen synthase kinase 3 alpha	19q13.2
808	CALM3	HEL-S-72 \| PHKD \| PHKD3	calmodulin 3 (phosphorylase kinase, delta)	19q13.2-q13.3
5296	PIK3R2	MPPH \| MPPH1 \| P85B \| p85 \| p85-BETA	phosphoinositide-3-kinase regulatory subunit 2	19q13.2-q13.4
5518	PPP2R1A	MRD36 \| PP2A-Aalpha \| PP2AAALPHA \| PR65A	protein phosphatase 2 regulatory subunit A, alpha	19q13.41
6195	RPS6KA1	HU-1 \| MAPKAPK1A \| RSK \| RSK1 \| p90Rsk	ribosomal protein S6 kinase A1	1p
4803	NGF	Beta-NGF \| HSAN5 \| NGFB	nerve growth factor	1p13.1
4893	NRAS	ALPS4 \| CMNS \| N-ras \| NCMS \| NRAS1 \| NS6	neuroblastoma RAS viral (v-ras) oncogene homolog	1p13.2
5906	RAP1A	C21KG \| G-22K \| KREV-1 \| KREV1 \| RAP1 \| SMGP21	RAP1A, member of RAS oncogene family	1p13.3
5567	PRKACB	PKA C-beta \| PKACB	protein kinase cAMP-activated catalytic subunit beta	1p31.1
2475	MTOR	FRAP \| FRAP1 \| FRAP2 \| RAFT1 \| RAPT1 \| SKS	mechanistic target of rapamycin	1p36.2
842	CASP9	APAF-3 \| APAF3 \| ICE-LAP6 \| MCH6 \| PPP1R56	caspase 9	1p36.21
4914	NTRK1	MTC \| TRK \| TRK1 \| TRKA \| Trk-A \| p140-TrkA	neurotrophic tyrosine kinase, receptor, type 1	1q21-q22
9261	MAPKAPK2	MAPKAP-K2 \| MK-2 \| MK2	mitogen-activated protein kinase-activated protein kinase 2	1q32
10000	AKT3	MPPH \| MPPH2 \| PKB-GAMMA \| PKBG \| PRKBG \| RAC-PK-gamma \| RAC-gamma \| STK-2	v-akt murine thymoma viral oncogene homolog 3	1q44
57761	TRIB3	C20orf97 \| NIPK \| SINK \| SKIP3 \| TRB3	tribbles pseudokinase 3	20p13-p12.2
6714	SRC	ASV \| SRC1 \| c-SRC \| p60-Src	SRC proto-oncogene, non-receptor tyrosine kinase	20q12-q13
5335	PLCG1	NCKAP3 \| PLC-II \| PLC1 \| PLC148 \| PLCgamma1	phospholipase C gamma 1	20q12-q13.1
7529	YWHAB	GW128 \| HEL-S-1 \| HS1 \| KCIP-1 \| YWHAA	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta	20q13.1
5594	MAPK1	ERK \| ERK-2 \| ERK2 \| ERT1 \| MAPK2 \| P42MAPK \| PRKM1 \| PRKM2 \| p38 \| p40 \| p41 \| p41mapk \| p42-MAPK	mitogen-activated protein kinase 1	22q11.21
135	ADORA2A	A2aR \| ADORA2 \| RDC8	adenosine A2a receptor	22q11.23
10126	DNAL4	MRMV3 \| PIG27	dynein axonemal light chain 4	22q13.1
5600	MAPK11	P38B \| P38BETA2 \| PRKM11 \| SAPK2 \| SAPK2B \| p38-2 \| p38Beta	mitogen-activated protein kinase 11	22q13.33
6300	MAPK12	ERK-6 \| ERK3 \| ERK6 \| MAPK 12 \| P38GAMMA \| PRKM12 \| SAPK-3 \| SAPK3	mitogen-activated protein kinase 12	22q13.33
5581	PRKCE	PKCE \| nPKC-epsilon	protein kinase C epsilon	2p21
805	CALM2	CAMII \| LQT15 \| PHKD \| PHKD2 \| caM	calmodulin 2 (phosphorylase kinase, delta)	2p21
109	ADCY3	AC-III \| AC3	adenylate cyclase 3	2p23.3
57498	KIDINS220	ARMS	kinase D-interacting substrate 220kDa	2p24
5899	RALB	-	v-ral simian leukemia viral oncogene homolog B	2q14.2
5136	PDE1A	CAM-PDE-1A \| HCAM-1 \| HCAM1 \| HSPDE1A	phosphodiesterase 1A	2q32.1
1385	CREB1	CREB \| CREB-1	cAMP responsive element binding protein 1	2q34
3667	IRS1	HIRS-1	insulin receptor substrate 1	2q36
1849	DUSP7	MKPX \| PYST2	dual specificity phosphatase 7	3p21
387	RHOA	ARH12 \| ARHA \| RHO12 \| RHOH12	ras homolog family member A	3p21.3
7867	MAPKAPK3	3PK \| MAPKAP-K3 \| MAPKAP3 \| MAPKAPK-3 \| MK-3	mitogen-activated protein kinase-activated protein kinase 3	3p21.3
5576	PRKAR2A	PKR2 \| PRKAR2	protein kinase cAMP-dependent type II regulatory subunit alpha	3p21.3-p21.2
5580	PRKCD	ALPS3 \| CVID9 \| MAY1 \| PKCD \| nPKC-delta	protein kinase C delta	3p21.31
5894	RAF1	CMD1NN \| CRAF \| NS5 \| Raf-1 \| c-Raf	Raf-1 proto-oncogene, serine/threonine kinase	3p25
5291	PIK3CB	P110BETA \| PI3K \| PI3KBETA \| PIK3C1	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta	3q22.3
5290	PIK3CA	CLOVE \| CWS5 \| MCAP \| MCM \| MCMTC \| PI3K \| p110-alpha	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha	3q26.3
1173	AP2M1	AP50 \| CLAPM1 \| mu2	adaptor related protein complex 2 mu 1 subunit	3q28
253260	RICTOR	AVO3 \| PIA \| hAVO3	RPTOR independent companion of MTOR, complex 2	5p13.1
108	ADCY2	AC2 \| HBAC2	adenylate cyclase 2 (brain)	5p15.3
5295	PIK3R1	AGM7 \| GRB1 \| IMD36 \| p85 \| p85-ALPHA	phosphoinositide-3-kinase regulatory subunit 1	5q13.1
4208	MEF2C	C5DELq14.3 \| DEL5q14.3	myocyte enhancer factor 2C	5q14.3
814	CAMK4	CaMK IV \| CaMK-GR \| IV \| caMK	calcium/calmodulin-dependent protein kinase IV	5q21.3
5515	PPP2CA	PP2Ac \| PP2CA \| PP2Calpha \| RP-C	protein phosphatase 2 catalytic subunit alpha	5q31.1
3710	ITPR3	IP3R \| IP3R3	inositol 1,4,5-trisphosphate receptor type 3	6p21
1026	CDKN1A	CAP20 \| CDKN1 \| CIP1 \| MDA-6 \| P21 \| SDI1 \| WAF1 \| p21CIP1	cyclin-dependent kinase inhibitor 1A	6p21.2
1432	MAPK14	CSBP \| CSBP1 \| CSBP2 \| CSPB1 \| EXIP \| Mxi2 \| PRKM14 \| PRKM15 \| RK \| SAPK2A \| p38 \| p38ALPHA	mitogen-activated protein kinase 14	6p21.3-p21.2
2309	FOXO3	AF6q21 \| FKHRL1 \| FKHRL1P2 \| FOXO2 \| FOXO3A	forkhead box O3	6q21
6196	RPS6KA2	HU-2 \| MAPKAPK1C \| RSK \| RSK3 \| S6K-alpha \| S6K-alpha2 \| p90-RSK3 \| p90RSK2 \| pp90RSK3	ribosomal protein S6 kinase A2	6q27
107	ADCY1	AC1 \| DFNB44	adenylate cyclase 1 (brain)	7p12.3
117	ADCYAP1R1	PAC1 \| PAC1R \| PACAPR \| PACAPRI	ADCYAP receptor type I	7p14
5898	RALA	RAL	v-ral simian leukemia viral oncogene homolog A (ras related)	7p15-p13
5575	PRKAR1B	PRKAR1	protein kinase cAMP-dependent type I regulatory subunit beta	7p22
5577	PRKAR2B	PRKAR2 \| RII-BETA	protein kinase cAMP-dependent type II regulatory subunit beta	7q22
673	BRAF	B-RAF1 \| BRAF1 \| NS7 \| RAFB1	B-Raf proto-oncogene, serine/threonine kinase	7q34
1846	DUSP4	HVH2 \| MKP-2 \| MKP2 \| TYP	dual specificity phosphatase 4	8p12-p11
114	ADCY8	AC8 \| ADCY3 \| HBAC1	adenylate cyclase 8 (brain)	8q24
1211	CLTA	LCA	clathrin light chain A	9p13
5568	PRKACG	BDPLT19 \| KAPG \| PKACg	protein kinase cAMP-activated catalytic subunit gamma	9q13
4915	NTRK2	GP145-TrkB \| TRKB \| trk-B	neurotrophic tyrosine kinase, receptor, type 2	9q22.1
53358	SHC3	N-Shc \| NSHC \| RAI \| SHCC	SHC (Src homology 2 domain containing) transforming protein 3	9q22.1
1759	DNM1	DNM \| EIEE31	dynamin 1	9q34
2889	RAPGEF1	C3G \| GRF2	Rap guanine nucleotide exchange factor 1	9q34.3
5900	RALGDS	RGDS \| RGF \| RalGEF	ral guanine nucleotide dissociation stimulator	9q34.3
2002	ELK1	-	ELK1, ETS transcription factor	Xp11.2
6197	RPS6KA3	CLS \| HU-3 \| ISPK-1 \| MAPKAPK1B \| MRX19 \| RSK \| RSK2 \| S6K-alpha3 \| p90-RSK2 \| pp90RSK2	ribosomal protein S6 kinase A3	Xp22.2-p22.1